{
  "actions": [
    {
      "acted_at": "2001-01-31", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2001-02-14", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr386-107", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "107", 
  "cosponsors": [
    {
      "district": "9", 
      "name": "Deal, Nathan", 
      "sponsored_at": "2001-02-28", 
      "state": "GA", 
      "thomas_id": "00277", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "4", 
      "name": "Schaffer, Bob", 
      "sponsored_at": "2001-02-27", 
      "state": "CO", 
      "thomas_id": "01524", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "6", 
      "name": "Tancredo, Thomas G.", 
      "sponsored_at": "2001-03-06", 
      "state": "CO", 
      "thomas_id": "01592", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-01-31", 
  "number": "386", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to orphan drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Orphan Drug Program Improvement Act of 2001", 
  "sponsor": {
    "district": "13", 
    "name": "Thornberry, Mac", 
    "state": "TX", 
    "thomas_id": "01155", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-01-31", 
  "subjects": [
    "Commerce", 
    "Drug approvals", 
    "Health", 
    "Labeling", 
    "Law", 
    "Licenses", 
    "Orphan drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-01-31", 
    "text": "Orphan Drug Program Improvement Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services, respecting application approval or licensing, to conform the designation of a drug for a rare disease or condition (orphan drug) to reflect such drug's approved labeling.Exempts clinically superior subsequent orphan drugs from the seven-year prohibition of approval respecting a previously approved or licensed drug."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Orphan Drug Program Improvement Act of 2001", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act with respect to orphan drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-14T18:57:05-04:00"
}